Evaluate the Efficacy and Safety of DWP05195 in Subjects With Post-Herpetic Neuralgia

NCT01557010 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

140

Enrollment

INDUSTRY

Sponsor class

Conditions

Postherpetic Neuralgia

Interventions

DRUG: DWP05195
DRUG: DWP05195
DRUG: DWP05195
DRUG: Control

Sponsor

Daewoong Pharmaceutical Co. LTD.